Growing evidence suggests that Aβ deposition in the brain initiates AD by inducing a chain of events involving the accumulation of toxic tau, which consequently leads to downstream neurodegeneration (Jack et al., 2013, 2014; Pereira et al., 2021). Here, MAPT is linked to Alzheimer disease.